Previous close | 15.96 |
Open | 15.96 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 15.96 - 15.96 |
52-week range | 15.96 - 20.63 |
Volume | |
Avg. volume | 387 |
Market cap | 7.497B |
Beta (5Y monthly) | 0.18 |
PE ratio (TTM) | 9.33 |
EPS (TTM) | 1.71 |
Earnings date | N/A |
Forward dividend & yield | 0.53 (3.31%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Q4 2023 Cue Biopharma Inc Earnings Call
Advancements in Clinical Trials and Strong Cash Position Highlighted
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that in order to accelerate the open innovation, it has increased its investment pool from US$100 million to US$200 million to continue strategic investment in Ono Venture Investment Fund I, L.P. ("OVI FI"), which was established as a corporate venture capital fund in CA, USA in May 2020.